Iovance Biotherapeutics
Wayland Wong is currently the Associate Director of Financial Planning & Analysis at Iovance Biotherapeutics, Inc. Prior to this, Wayland held a position as the Business and Financial Consultant at Controller's Group, Inc. & Personal Clients. With vast experience in finance management, Wayland worked as the Finance Manager for healthcare/life sciences accounts at Hewlett Packard Enterprise for almost two decades. Wayland also had experience as a District Manager at Fortis Investors. Wayland holds an MBA from the University of California, Berkeley, Haas School of Business, and a BA in Economics & Business Admin Minor from the same institution.
Iovance Biotherapeutics
6 followers
Iovance Biotherapeutics (NASDAQ: IOVA) aims to improve patient care for people living with cancer. Iovance is investigating T cell-based therapies, known as tumor infiltrating lymphocytes (TIL), which use a patient’s own immune cells to attack cancer.